CHRNB3, cholinergic receptor nicotinic beta 3 subunit, 1142
N. diseases: 28; N. variants: 11
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
8 | 42697765 | intron variant | G/T | snv | 0.60 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
8 | 42724596 | intron variant | T/C | snv | 0.60 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
8 | 42734459 | intron variant | A/C;G | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
8 | 42705193 | intron variant | A/C;T | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||||
|
8 | 42707795 | intron variant | G/A | snv | 0.60 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
8 | 42705106 | intron variant | A/G | snv | 0.60 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
0.925 | 0.080 | 8 | 42732292 | missense variant | C/T | snv | 3.6E-04 | 4.9E-04 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.925 | 0.080 | 8 | 42732292 | missense variant | C/T | snv | 3.6E-04 | 4.9E-04 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.925 | 0.080 | 8 | 42731922 | synonymous variant | C/T | snv | 4.3E-02 | 3.2E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.925 | 0.080 | 8 | 42731922 | synonymous variant | C/T | snv | 4.3E-02 | 3.2E-02 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
1.000 | 0.040 | 8 | 42732516 | synonymous variant | G/A;C;T | snv | 4.2E-05; 4.7E-02; 4.2E-06 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.160 | 8 | 42704443 | 5 prime UTR variant | G/A | snv | 0.62 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.160 | 8 | 42704443 | 5 prime UTR variant | G/A | snv | 0.62 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.160 | 8 | 42704443 | 5 prime UTR variant | G/A | snv | 0.62 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.160 | 8 | 42704443 | 5 prime UTR variant | G/A | snv | 0.62 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.851 | 0.160 | 8 | 42704443 | 5 prime UTR variant | G/A | snv | 0.62 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.160 | 8 | 42704443 | 5 prime UTR variant | G/A | snv | 0.62 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 8 | 42704443 | 5 prime UTR variant | G/A | snv | 0.62 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
8 | 42696018 | upstream gene variant | A/C;G | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2010 | 2010 |